We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide to Epclusa, detailing its dosage, strengths, and how to take it for Hepatitis C treatment in India. Learn about forms, administration, and important considerations.

Hepatitis C is a viral infection that primarily affects the liver. In India, like in many parts of the world, it remains a significant public health concern. Fortunately, advancements in medical science have led to highly effective treatments, and Epclusa is one such breakthrough medication. This article provides a comprehensive guide to Epclusa, focusing on its dosage, strengths, and how to take it, tailored for an Indian audience.
Epclusa is a prescription medication used to treat chronic Hepatitis C infection in adults and certain children. It belongs to a class of drugs known as direct-acting antivirals (DAAs). Epclusa contains two active ingredients: sofosbuvir and velpatasvir. These components work together to inhibit the replication of the Hepatitis C virus, helping your body clear the infection.
Epclusa is available in two forms:
Each form comes in specific strengths:
The dosage of Epclusa is determined by your doctor based on several factors, including the severity of your Hepatitis C infection, the presence of cirrhosis (liver scarring), and your overall health.
The usual dose is one 400 mg sofosbuvir/100 mg velpatasvir tablet taken once daily for 12 weeks. Compensated cirrhosis means the liver is scarred but still functioning adequately.
If you have decompensated cirrhosis (advanced liver disease), your doctor will likely prescribe Epclusa in combination with another antiviral medication called ribavirin. The treatment duration remains 12 weeks, but the specific dosage of both Epclusa and ribavirin will be carefully managed by your physician.
If swallowing tablets is a challenge, your doctor may prescribe Epclusa pellets. The typical dose involves taking two pellets of 200 mg sofosbuvir/50 mg velpatasvir to achieve the equivalent of the 400 mg/100 mg daily dose. This regimen is also taken for 12 weeks.
Epclusa is also approved for use in children aged 3 years and older. The dosage for children is determined by their body weight. The treatment duration for children is also typically 12 weeks. Your child's pediatrician will provide specific dosing instructions.
It is crucial to follow your doctor's instructions precisely when taking Epclusa.
The typical treatment duration for Epclusa is 12 weeks. However, your doctor will determine the exact length of your treatment based on your individual response to the medication and the severity of your Hepatitis C infection. In some cases, Epclusa might be prescribed alone, while in others, it may be combined with ribavirin for the same 12-week period.
Like all medications, Epclusa can cause side effects. Common side effects may include fatigue, headache, nausea, and insomnia. Less common but more serious side effects can occur. It is essential to discuss any concerns with your doctor. If you experience severe or persistent side effects, seek medical attention immediately.
You should consult your doctor or healthcare provider in the following situations:
While Epclusa is a treatment, preventing Hepatitis C infection is crucial. The virus is spread through contact with infected blood. Key preventive measures include:
Epclusa has revolutionized Hepatitis C treatment, offering a high cure rate with a manageable treatment regimen. Understanding the correct dosage, strengths, and how to take the medication is vital for successful treatment. Always adhere to your doctor's prescription and discuss any questions or concerns you may have. Early diagnosis and treatment are key to managing Hepatitis C effectively and preventing long-term liver damage.

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and what results mean for patients.
April 20, 2026

Discover how specialized staining techniques, like Giemsa, are crucial for accurately diagnosing Leishmaniasis, identifying the parasite, and guiding timely treatment. Understand this key diagnostic approach.
April 20, 2026

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and why it's a vital tool in combating this disease.
April 20, 2026